Builds an MRI-compatible surgical robot that lets neurosurgeons place leads, take biopsies and ablate tumors while the patient is inside the scanner. It won a $2 million Phase II SBIR from the National Cancer Institute in September 2026.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.